159 related articles for article (PubMed ID: 31040200)
1. Serum proteomics identify potential biomarkers for nasopharyngeal carcinoma sensitivity to radiotherapy.
Zhang G; Zhang K; Li C; Li Y; Li Z; Li N; Zhou Q; Shen L
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31040200
[TBL] [Abstract][Full Text] [Related]
2. A five-variable signature predicts radioresistance and prognosis in nasopharyngeal carcinoma patients receiving radical radiotherapy.
Yi HM; Yi H; Zhu JF; Xiao T; Lu SS; Guan YJ; Xiao ZQ
Tumour Biol; 2016 Mar; 37(3):2941-9. PubMed ID: 26409455
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma.
Li S; Liu T; Mo W; Hou Q; Zhou Y; Liu M; He Z; Liu Z; Chen Q; Wang H; Guo X; Xia W; Zeng M; Zhao H
Radiat Oncol; 2016 Sep; 11(1):121. PubMed ID: 27647315
[TBL] [Abstract][Full Text] [Related]
4. Identification of ERp29 as a biomarker for predicting nasopharyngeal carcinoma response to radiotherapy.
Wu P; Zhang H; Qi L; Tang Q; Tang Y; Xie Z; Lv Y; Zhao S; Jiang W
Oncol Rep; 2012 Apr; 27(4):987-94. PubMed ID: 22160175
[TBL] [Abstract][Full Text] [Related]
5. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
[TBL] [Abstract][Full Text] [Related]
6. Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics.
Feng XP; Yi H; Li MY; Li XH; Yi B; Zhang PF; Li C; Peng F; Tang CE; Li JL; Chen ZC; Xiao ZQ
Cancer Res; 2010 May; 70(9):3450-62. PubMed ID: 20406978
[TBL] [Abstract][Full Text] [Related]
7. AKR1B10 confers resistance to radiotherapy via FFA/TLR4/NF-κB axis in nasopharyngeal carcinoma.
Liu X; Hu Z; Qu J; Li J; Gong K; Wang L; Jiang J; Li X; He R; Duan L; Luo W; Xia C; Luo D
Int J Biol Sci; 2021; 17(3):756-767. PubMed ID: 33767586
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the differential secretome of nasopharyngeal carcinoma cell lines CNE-2R and CNE-2.
Chen ZT; Li L; Guo Y; Qu S; Zhao W; Chen H; Su F; Yin J; Mo QY; Zhu XD
Oncol Rep; 2015 Nov; 34(5):2477-88. PubMed ID: 26352878
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic values of serum cathepsin B and D in patients with nasopharyngeal carcinoma.
Tan G; Liu Q; Tang X; Kang T; Li Y; Lu J; Zhao X; Tang F
BMC Cancer; 2016 Mar; 16():241. PubMed ID: 26995190
[TBL] [Abstract][Full Text] [Related]
10. Regenerating gene IA predicts radiosensitivity and survival in nasopharyngeal carcinoma.
Xing HJ; Chen XD; Sun HX; Dai YZ; Han YF; Ding LL; Liu JH; Chen HB
J Physiol Pharmacol; 2022 Feb; 73(1):. PubMed ID: 35793764
[TBL] [Abstract][Full Text] [Related]
11. Analysis of serum proteome profiles in nasopharyngeal carcinoma with different radiosensitivity.
Su F; Zhu X; Liang Z; Li L; Qu S; Liang X; Wang Q; Liang S; Chen L
Clin Transl Oncol; 2014 Feb; 16(2):147-52. PubMed ID: 23670049
[TBL] [Abstract][Full Text] [Related]
12. Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity.
Yuan L; Yi HM; Yi H; Qu JQ; Zhu JF; Li LN; Xiao T; Zheng Z; Lu SS; Xiao ZQ
Oncotarget; 2016 Mar; 7(10):11463-77. PubMed ID: 26862850
[TBL] [Abstract][Full Text] [Related]
13. miR‑495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells.
Feng X; Lv W; Wang S; He Q
Oncol Rep; 2018 Sep; 40(3):1223-1232. PubMed ID: 30015969
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of β-Catenin Decreases the Radiosensitivity of Human Nasopharyngeal Carcinoma CNE-2 Cells.
He H; Lin K; Su Y; Lin S; Zou C; Pan J; Zhou Y; Chen C
Cell Physiol Biochem; 2018; 50(5):1929-1944. PubMed ID: 30396174
[TBL] [Abstract][Full Text] [Related]
15. [A pilot investigation on serum protein fingerprinting of nasopharyngeal carcinoma].
Huang XW; Zhou W; Chen J; Chu HQ; Xiao CW; Hua XY; Zhang P; Li HQ; Cui YH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jun; 46(6):509-12. PubMed ID: 21924105
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
[TBL] [Abstract][Full Text] [Related]
17. Identification of radioresistance-associated proteins in human nasopharyngeal carcinoma cell lines by proteomic analysis.
Li L; Huang S; Zhu X; Zhou Z; Liu Y; Qu S; Guo Y
Cancer Biother Radiopharm; 2013 Jun; 28(5):380-4. PubMed ID: 23464856
[TBL] [Abstract][Full Text] [Related]
18. Profiling of Tumor Cell-Delivered Exosome by Surface Enhanced Raman Spectroscopy-Based Biosensor for Evaluation of Nasopharyngeal Cancer Radioresistance.
Wu Q; Ding Q; Lin W; Weng Y; Feng S; Chen R; Chen C; Qiu S; Lin D
Adv Healthc Mater; 2023 Mar; 12(8):e2202482. PubMed ID: 36528342
[TBL] [Abstract][Full Text] [Related]
19. Extensive serum biomarker analysis in patients with nasopharyngeal carcinoma.
Gong D; Li Z; Ding R; Cheng M; Huang H; Liu A; Kang M; He H; Xu Y; Shao J; Wang Y; Duan C
Cytokine; 2019 Jun; 118():107-114. PubMed ID: 29759660
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B.
Li G; Liu Y; Su Z; Ren S; Zhu G; Tian Y; Qiu Y
Eur J Cancer; 2013 Jul; 49(11):2596-607. PubMed ID: 23583221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
